Join to View Full Profile
555 W Crosstown PkwySte 201Kalamazoo, MI 49008
Phone+1 269-532-1590
Fax+1 574-252-4161
Dr. Swartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 1982 - 1985
Yale-New Haven Medical CenterFellowship, Allergy and Immunology, 1981 - 1982- Yale-New Haven Medical CenterResidency, Internal Medicine, 1978 - 1981
Yale School of MedicineClass of 1978
Certifications & Licensure
MI State Medical License 1993 - 2027
AR State Medical License 2023 - 2024
ID State Medical License 2022 - 2024
IL State Medical License 1985 - 2002
MD State Medical License 1982 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2012, 2014-2015
- CMS Meaningful Use Stage 1 Certification PowerChart (All CQM's), Cerner Corporation, 2012, 2014-2015
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2012, 2014-2015
Clinical Trials
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Publications & Presentations
PubMed
- 40 citationsPatient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.Richard J. Martin, Andrew J Head, Jonathan René, Timothy J Swartz, Justus J Fiechtner
The Journal of Rheumatology. 2008-04-01 - 4 citationsInsecticide-induced lupus erythematosus.Kenneth Beer, Allan L. Lorincz, Maria Medenica, John Albertini, Joseph M. Baron
International Journal of Dermatology. 1994-12-01 - 57 citationsEffects of administration of an anti‐cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studiesVibeke Strand, Peter E. Lipsky, Grant W. Cannon, Leonard H. Calabrese, Craig Wiesenhutter
Arthritis and Rheumatism. 1993-05-01
Press Mentions
- Daily Foot Temperature Monitoring Leads to Fewer Hospitalizations, Amputations and MoreOctober 14th, 2020
- Study: Pathbreaking Technology Completely Eliminated Major Diabetic AmputationsOctober 14th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
